Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT03694938
Active, not recruiting Not applicable

Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients

NCT03694938 · tracked via the Priya Life Science France tracker
Sponsor
Poitiers University Hospital
Phase
Not applicable
Started
2019-02-07
Last updated
2025-07-20

Condition(s) studied

Metastatic Colon Cancer

Investigational drug(s) / intervention(s)

Magnetic resonance imaging

Magnetic resonance imaging: Annually magnetic resonance imaging

Study summary

The aim of this study is to prospectively determine the incidence of brain metastases in metastatic colorectal cancer patients using systematic annual screening by MRI.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with histologically proven colorectal adenocarcinoma * Metastases from colorectal cancer diagnosed since less than 6 months * Indication of an oncologic treatment Exclusion Criteria: * Patient with contraindication for MRI * Diagnosis of cancer other than colorectal cancer in the last three years, except in situ cancers, basal-cell skin cancer or squamous-cell skin cancer, and other cancer with low risk of brain dissemination according to the investigator * Pregnant or breastfeeding women, women of childbearing potential without effective contraception

Primary outcome measure(s)

  • Prospectively determine the incidence of brain metastases in metastatic colorectal cancer patients with annual MRI. — 3 years
    Diagnostic of brain metastases on annual MRI

Trial sites (4)

FacilityCityRegionStatus
C.H.U. d'Amiens Amiens France
Hôpital Privé Jean Mermoz Lyon France
C.H.U. de Poitiers Poitiers France
C.H.U. de Tours Tours France

More Poitiers University Hospital trials in France

Interventions to Remedy the Negative Effects of Obesity Stigma Recruiting
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). Active, not recruiting
Ventricular Arrhythmias in Acute Myocardial Infarction Recruiting
Impact on Prognosis of Increased Sleep Quality Obtained by Personalized Night-time Nursing Care in Critically Ill Patients Recruiting
Reducing Burnout in Healthcare Workers Through Yoga and Square Breathing Practices Recruiting

Other trials for the same condition

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03694938 on ClinicalTrials.gov ↗ ← All trials in France